BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aslani M, Mortazavi-Jahromi SS, Mirshafiey A. Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs. Int Immunopharmacol 2021;101:108172. [PMID: 34601331 DOI: 10.1016/j.intimp.2021.108172] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Charles J, Ploplis VA. COVID-19 Induces Cytokine Storm and Dysfunctional Hemostasis. Curr Drug Targets 2022;23:1603-10. [PMID: 36284376 DOI: 10.2174/1389450124666221025102929] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Arisan ED, Dart DA, Grant GH, Dalby A, Kancagi DD, Turan RD, Yurtsever B, Karakus GS, Ovali E, Lange S, Uysal-onganer P. microRNA 1307 Is a Potential Target for SARS-CoV-2 Infection: An in Vitro Model. ACS Omega. [DOI: 10.1021/acsomega.2c05245] [Reference Citation Analysis]
3 Mortazavi-Jahromi SS, Aslani M. Dysregulated miRNAs network in the critical COVID-19: An important clue for uncontrolled immunothrombosis/thromboinflammation. Int Immunopharmacol 2022;110:109040. [PMID: 35839566 DOI: 10.1016/j.intimp.2022.109040] [Reference Citation Analysis]
4 Rubio-casillas A, Gupta RC, Redwa EM, Uversky VN, Badierah R. Early taurine administration as a means for halting the cytokine storm progression in COVID-19 patients. Exploration of Medicine 2022. [DOI: 10.37349/emed.2022.00088] [Reference Citation Analysis]
5 Hamdy NM, Shaker FH, Zhan X, Basalious EB. Tangled quest of post-COVID-19 infection-caused neuropathology and what 3P nano-bio-medicine can solve? EPMA J 2022;:1-24. [PMID: 35668839 DOI: 10.1007/s13167-022-00285-2] [Reference Citation Analysis]
6 Ibáñez AJ. How Is Mass Spectrometry Tackling the COVID-19 Pandemic? Front Anal Sci 2022;2. [DOI: 10.3389/frans.2022.846102] [Reference Citation Analysis]
7 Maitz T, Parfianowicz D, Vojtek A, Rajeswaran Y, Vyas AV, Gupta R. COVID-19 Cardiovascular Connection: A Review of Cardiac Manifestations in COVID-19 Infection and Treatment Modalities. Current Problems in Cardiology 2022. [DOI: 10.1016/j.cpcardiol.2022.101186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Vastrad B, Vastrad C. Comprehensive analysis of next-generation sequencing data in COVID-19 and its secondary complications.. [DOI: 10.1101/2022.02.03.478930] [Reference Citation Analysis]
9 Wilson JC, Kealy D, James SR, Plowman T, Newling K, Jagger C, Filbey K, Mann ER, Konkel JE, Menon M, Knight SB, Simpson A, Prihartadi A, Forshaw G, Todd N, Yates DR, Grainger JR, Hussell T, Kaye PM, Signoret N, Lagos D. Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19. iScience 2022;25:103672. [DOI: 10.1016/j.isci.2021.103672] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
10 Bautista-Becerril B, Pérez-Dimas G, Sommerhalder-Nava PC, Hanono A, Martínez-Cisneros JA, Zarate-Maldonado B, Muñoz-Soria E, Aquino-Gálvez A, Castillejos-López M, Juárez-Cisneros A, Lopez-Gonzalez JS, Camarena A. miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19. Viruses 2021;14:41. [PMID: 35062245 DOI: 10.3390/v14010041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]